BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• BioCapital

  Trevigen Launches LDEV Free Basement Membrane Extract

  March 31, 2008

   · 

  1 min read
• UNIchip Protein Biochips from Protagen AG Identify Significant Off-Target Binding for TNF-alpha Inhibitors

  March 31, 2008

   · 

  2 min read
• Business

  Encorium Group, Inc. Announces $1.6 Million Contract for a Phase 2 Trial of an Innovative Immunotherapeutic Vaccine for the Treatment of Hypertension

  March 31, 2008

   · 

  1 min read
• Business

  Crucell N.V. Announces Start of Phase II Clinical Study Rabies Monoclonal Antibody Combination in US; First Milestone Achieved in Collaboration Agreement with Sanofi Pasteur

  March 31, 2008

   · 

  1 min read
• Biotech Beach

  Cortex Pharmaceuticals, Inc. Initiates Enrollment in Opiate Induced Respiratory Depression Clinical Trial in Germany Today

  March 31, 2008

   · 

  1 min read
• Drug Development

  Update on Merck & Co., Inc.'s Investigational Extended-Release Niacin/Laropiprant; Patient Enrollment Placed on Hold

  March 31, 2008

   · 

  3 min read
• Drug Development

  Boehringer Ingelheim Corporation Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population

  March 31, 2008

   · 

  10 min read
• BioMidwest

  Encision, Inc. Moves Power and Safety to Surgeons’ Fingertips

  March 31, 2008

   · 

  2 min read
• Business

  Synergetics USA, Inc. Merges Its Philadelphia Production Plant into Its O’Fallon Facility

  March 31, 2008

   · 

  2 min read
• Biotech Bay

  MPM Capital and NEA Lead $65 million Series A Preferred Round to Finance Spinout of TriVascular, Inc. from Boston Scientific Corporation

  March 31, 2008

   · 

  6 min read